ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

28,996Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 129

$1.85M Total Retail Price of All Prescriptions

Rank: 1 out of 129

1,261 Patients Receiving at Least One Drug in Part D
64%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 1,261 patients filled at least one prescription for a schedule two drug, compared to an average of 0%.

Schedule Three
Controlled Substances

33% of this provider’s 1,261 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

4% of this provider’s 17,638 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
HYDROCODONE-ACETAMINOPHEN 1,502 696 S3 1 26
SIMVASTATIN 846 628 2 4
OMEPRAZOLE 827 542 3 25
GABAPENTIN 747 386 4 42
TRAMADOL HCL 733 404 5 44
FUROSEMIDE 662 433 6 7
LEVOTHYROXINE SODIUM 648 489 7 23
POTASSIUM CHLORIDE 532 355 8 13
SPIRONOLACTONE 530 325 9 21
PRAVASTATIN SODIUM 522 332 10 12
WARFARIN SODIUM 518 398 11 10
METFORMIN HCL 499 233 12 38
LISINOPRIL 438 279 13 1
AMLODIPINE BESYLATE 431 285 14 3
CLOPIDOGREL 421 295 15 5
ATENOLOL 407 259 16 18
MELOXICAM 385 131 17 50
METOPROLOL TARTRATE 381 298 18 8
CARVEDILOL 313 188 19 2
TAMSULOSIN HCL 295 213 20 72
METOPROLOL SUCCINATE 280 205 21 6
PLAVIX 276 188 22 11
NITROSTAT 271 173 23 24
DIGOXIN 267 175 24 14
RANEXA 258 184 25 31
SERTRALINE HCL 257 156 26 79
ROPINIROLE HCL 257 167 26 100
CYMBALTA 256 98 28 88
TRAZODONE HCL 254 128 29 101
PREDNISONE 252 144 30 80
ZOLPIDEM TARTRATE 249 105 31 47
DONEPEZIL HCL 241 223 32 70
ALLOPURINOL 220 153 33 55
CIPROFLOXACIN HCL 217 125 34 68
NEXIUM 217 127 34 52
ISOSORBIDE MONONITRATE ER 213 153 36 15
GLYBURIDE 209 130 R 37 108
PROAIR HFA 206 97 38 95
SPIRONOLACTONE-HCTZ 202 129 39 111
DIOVAN 201 182 40 22
LISINOPRIL-HYDROCHLOROTHIAZIDE 200 123 41 35
MEGESTROL ACETATE 198 180 R 42 114
CEFUROXIME 195 134 43 115
LOSARTAN POTASSIUM 191 122 44 19
LYRICA 187 65 45 86
TORSEMIDE 185 105 46 33
GLIMEPIRIDE 166 119 47 106
MIRTAZAPINE 159 120 48 124
LANTUS 155 105 49 102
AMIODARONE HCL 154 122 50 20
RANITIDINE HCL 153 99 51 77
ALENDRONATE SODIUM 148 84 52 108
SPIRIVA 144 87 53 130
ATORVASTATIN CALCIUM 136 106 54 9
HYDROXYZINE HCL 135 40 R 55 134
OXYCODONE HCL 133 32 S2 56 135
CYCLOBENZAPRINE HCL 130 61 R 57 98
PROMETHAZINE HCL 126 66 R 58 116
PAROXETINE HCL 124 69 59 91
POLYETHYLENE GLYCOL 3350 122 92 60 137
AMOX TR-POTASSIUM CLAVULANATE 122 83 60 137
CILOSTAZOL 121 51 62 53
ADVAIR DISKUS 119 79 63 97
DIOVAN HCT 119 96 63 45
LACTULOSE 119 70 63 139
ABILIFY 116 47 66 142
FLUOXETINE HCL 115 47 67 143
PREMARIN 115 62 R 67 110
RISPERIDONE 112 69 69 144
LEVEMIR 111 86 70 145
SOTALOL 110 68 71 34
QUETIAPINE FUMARATE 110 40 71 146
CEPHALEXIN 109 67 73 99
CARISOPRODOL 107 12 R 74 92
CRESTOR 102 60 75 16
CITALOPRAM HBR 99 74 76 75
HYDROCHLOROTHIAZIDE 98 80 77 17
HYDRALAZINE HCL 98 65 77 37
SUCRALFATE 97 61 79 151
DILTIAZEM 24HR CD 96 59 80 39
AMITRIPTYLINE HCL 92 28 R 81 119
LIDODERM 90 54 82 153
KLOR-CON M20 89 35 83 41
GLIPIZIDE 87 69 84 106
LEVETIRACETAM 86 36 85 155
METRONIDAZOLE 85 52 86 156
CLONIDINE HCL 85 42 86 36
BUMETANIDE 84 54 88 61
LOSARTAN-HYDROCHLOROTHIAZIDE 83 69 89 64
THEOPHYLLINE ANHYDROUS 80 35 90 161
PRADAXA 79 67 91 28
LANTUS SOLOSTAR 78 34 92 162
NOVOLIN R 76 55 93 163
PANTOPRAZOLE SODIUM 75 29 94 43
VENTOLIN HFA 74 12 95 165
VOLTAREN 74 54 95 165
NAMENDA 73 67 97 125
MUPIROCIN 73 44 97 168
FLUTICASONE PROPIONATE 71 49 99 122
INSULIN SYRINGE 71 43 99 127
GEMFIBROZIL 70 25 101 65
TOPIRAMATE 70 0 101 169
AMOXICILLIN 67 36 103 129
SYMBICORT 67 48 103 171
FLUCONAZOLE 67 43 103 171
ESTRADIOL 64 22 R 106 174
BUPROPION HCL SR 64 12 106 174
COMBIVENT 64 32 106 174
VENLAFAXINE HCL ER 63 28 109 177
BYSTOLIC 60 31 110 27
AZITHROMYCIN 60 33 110 111
PEN NEEDLE 59 33 112 183
PROPRANOLOL HCL 59 32 112 113
LIPITOR 58 43 114 46
DIVALPROEX SODIUM 57 29 115 186
EXELON 57 51 115 186
DILTIAZEM 24HR ER 56 24 117 82
METHOCARBAMOL 56 0 R 117 191
GENTAMICIN SULFATE 56 37 117 191
SULFAMETHOXAZOLE-TRIMETHOPRIM 54 29 120 194
DILTIAZEM ER 53 28 121 61
TIZANIDINE HCL 53 0 121 195
VERAPAMIL ER 52 28 123 54
PRIMIDONE 52 43 123 197
DETROL LA 51 22 125 201
AVODART 51 39 125 201
ISOSORBIDE MONONITRATE 50 42 127 81
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 23, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.